Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$11,602
in 1 filing
Open-market sales, last 90 days
$117,428
in 4 filings, $104K under 10b5-1 plans

Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 94 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-19 Wong Stephanie Director Returned to the company · Stock Option (right to buy) −24,999 0
2026-03-19 Wong Stephanie Director Grant or award · Stock Option (right to buy) +10,362 10,362
2026-03-19 Wong Stephanie Director Returned to the company · Stock Option (right to buy) −10,362 0
2026-03-19 Wong Stephanie Director Grant or award · Stock Option (right to buy) +23,742 23,742
2026-03-19 Wong Stephanie Director Returned to the company · Stock Option (right to buy) −23,742 0
2026-03-19 Zakrzewski Joseph S Director Grant or award · Stock Option (right to buy) +99,999 99,999
2026-03-19 Zakrzewski Joseph S Director Returned to the company · Stock Option (right to buy) −99,999 0
2026-03-19 Zakrzewski Joseph S Director Grant or award · Stock Option (right to buy) +10,362 10,362
2026-03-19 Zakrzewski Joseph S Director Returned to the company · Stock Option (right to buy) −10,362 0
2026-03-19 Zakrzewski Joseph S Director Grant or award · Stock Option (right to buy) +23,742 23,742
2026-03-19 Zakrzewski Joseph S Director Returned to the company · Stock Option (right to buy) −23,742 0
2026-03-19 Eizen Joshua M See Remarks Grant or award · Stock Option (right to buy) +92,000 92,000
2026-03-19 Eizen Joshua M See Remarks Returned to the company · Stock Option (right to buy) −92,000 0
2026-03-19 Eizen Joshua M See Remarks Grant or award · Stock Option (right to buy) +50,150 50,150
2026-03-19 Eizen Joshua M See Remarks Returned to the company · Stock Option (right to buy) −50,150 0
2026-03-19 Spigelman Melvin K Director Grant or award · Stock Option (right to buy) +16,941 16,941
2026-03-19 Spigelman Melvin K Director Returned to the company · Stock Option (right to buy) −16,941 0
2026-03-19 Spigelman Melvin K Director Grant or award · Stock Option (right to buy) +10,362 10,362
2026-03-19 Spigelman Melvin K Director Returned to the company · Stock Option (right to buy) −10,362 0
2026-03-19 Spigelman Melvin K Director Grant or award · Stock Option (right to buy) +23,742 23,742

Page 4 of 10 · 191 trades